Mark J. Holdbrook

All filings by Mark J. Holdbrook on record concern Tarsus Pharmaceuticals, Inc. Over a trading history stretching from 15 March 2023 to 20 March 2023, the count stands at 4 filings.

Sales make up the whole of the open-market record (3 sales, €7,063). Outside the open market, there are 1 option exercise.

The newest entry dates from 21 March 2023: an open-market sale of €2,338, in Tarsus Pharmaceuticals, Inc. Typically, a trade is published a median of 2 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.